Abstract Renal osteodystrophy (ROD) is a multifac-Key words: aluminium bone deposits; bone iron overtorial disease. Aluminium deposits have been implic-load; iron bone deposits; renal osteodystrophy ated in its physiopathology but iron deposits have seldom been described. The purpose of this study was to investigate the presence of iron on the mineralization front, in 70 patients with ROD. Their mean age was 48±16 years, 36 were female, 34 male, 55 were admit-Introduction ted on peritoneal dialysis (78.5%) and 15 to haemodialysis (21.5%), for a period of 28±22 months. A bone In the last two decades, aluminium bone deposits have biopsy was obtained from each patient after double been widely studied in renal osteodystrophy, particutetracycline labelling. Blood samples were also larly in patients undergoing haemodialysis [1] [2] [3] . obtained at the time of bone biopsy. The histomopho-Aluminium has been implicated in the genesis of metric analysis was performed following the criteria of encephalopathy, low bone turnover, hypoparathyroidSherrard et al., with slight modifications; beside the ism, anaemia, osteomalacia and adynamic bone disease usual stains, aluminium, iron and amyloid stainings in dialysis subjects [4] [5] [6] [7] [8] [9] [10] [11] . Although the role of alumiwere done on all bone specimens. Biochemical findings nium is beyond question, iron has been less studied, were: Ca 8.8±0.9 mg/dl, P 6.1±1.5 mg/dl; total alkalbut has occasionally been reported to co-exist with ine phosphatase 197±258; PTHm 4.9±4.05 ng/ml aluminium on the bone mineralization front, and some (normal 0.4-0.7 ng/ml ), calcitonin 11±6 pg/ml investigators have proposed that it may have similar (normal 1-26 pg/ml ). Osteitis fibrosa was found in 31 toxic effects [12,13]. Recently, other trace elements patients (44.28%), mixed bone disease in two patients have been investigated, but their role, particularly the (2.28%); mild bone disease in 20 subjects (28.57%), issue of whether clinical disturbances result from accuadynamic bone lesion in 15 cases (21.42%) and osteomulation (toxicity) or depletion (deficiency) has malacia in two patients (2.28%). Iron deposits were remained unclear. Histochemically we frequently have found on the mineralization front in 43 patients seen iron deposits in the mineralization front in our (61.4%); in 17, the percentage was <25 and, in 26, bone biopsy studies [14,15]. The purpose of this study >25%. The iron deposits in the osteitis fibrosa group was to investigate the presence of iron in the mineralizwere highly significant (25/31). The aluminium deposit ation front in patients with renal osteodystrophy. at the mineralization front was observed in eight patients (11.4%); in all but one, the percentage of this metal was <10%. Amyloid deposits were negative in all cases. The results show: (i) a Mexican population with ROD, present a highly significant incidence of Subjects and methods siderosis on the bone mineralization front; (ii) in contrast, the aluminium deposits in this group of A prospective cross-sectional study was performed in 70 patients is lower than that reported in other series, and patients, 34 males and 36 women with chronic renal failure (iii) the spectrum of RO in this Mexican population is (CRF ) undergoing dialysis. The mean age was 48±16 years. similar to that reported in other studies.
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Fifty five patients were on chronic peritoneal dialysis (CAPD) and 15 on haemodialysis (HD) for a mean period of 28±22 months. A bone biopsy was obtained after double tetracycline labelling in all patients. In the same week, blood samples
Laboratory measurements
determined. The normal bone biopsy indexes were obtained in bone specimens taken from 10 normal subjects of the Serum calcium was determined with atomic absorption same age and body weight and studied with the same (Perkin Elmer); serum creatinine, urea, phosphorus, total methodology in our laboratory. alkaline phosphatase and albumin were quantified with a Biopsies were classified according to Sherrard et al.
[20] computerized Technicon Autoanalyzer. The serum concen-and the results are summarized in Table 1 . tration of calcitonin and parathyroid hormone (PTH ) was
The five groups were defined quantitatively as: osteitis estimated with a middle molecule radioimmunoassay fibrosa when the percentage of total bone area of osteoid (INCSTAR kit; normal range 0.32-0.65 ng/ml ).
was <12 and when the percentage of total bone area of fibrosis was >0.5; mixed when the percentage of total bone area of osteoid was >12 and when the percentage of total Bone histomorphometry bone area of fibrosis was >0.5; mild when the percentage of total bone area of osteoid was <12 with the percentage of total bone area of fibrosis <0.5 and bone formation rate After double tetracycline labelling with a 10 day interval >1100 m2/mm2/day; adynamic when the percentage of total between doses, full thickness bone biopsy was obtained from bone area of osteoid was <12 with the percentage of the iliac bone. The non-decalcified bone specimen was fixed total bone area of fibrosis <0.5 and bone formation rate with ethanol and embedded in methylmethacrylate and sec-<1100 m2/mm2/day; and osteomalacia when the percentage tioned for histomorphological examination. Bone samples of total bone area of osteoid was >12 and the percentage were stained with Goldner tricrome, aluminium according to of total bone area of fibrosis was <0.5. The 10 normal a modification of the method of Maloney et al. method [16 ] , subjects were submitted to surgery for monostotic benign iron with Perl's method [17] and amyloid with Bennhol's bone dysplasias. For our histomorphometric data, the congo red [18] . We stained all bone sections for aluminium nomenclature of the ASBMR histomorphometry committee and iron using a control obtained from the iliac bone of rats was followed [21, 22] . The study was approved by each loaded with both metals. The amounts of iron and aluminium Institutional Research Ethic Committee and informed conwere estimated on the bone spicula peripheral surface with sent was obtained from each patient. the Merz-Schenk reticle in a minimum of 25 fields. The percentage of the metal present on the surface of the spiculae was calculated, multiplying by 100 the number of times that Statistical analysis the waves of the reticle made contact with the metal, and the value obtained was divided by the total sum of the number of times that the waves of the reticle contact or All values are expressed as mean±standard deviation of the touch the peripheral surface of the spiculae.
mean. The non-paired Student's t-test was utilized to analyse All histomorphometric analyses were done with the aid of the differences between the static and dynamic indexes and a light microscope with a Merz-Schenk reticle [19] and an the normal bone biopsies. The x2 test was used to analyse eyepiece micrometer. Measurement of cancellous bone was differences between percentages. P values <0.05 were considdivided into the following normal index values. ered significant.
Static index

Results
The iron deposits (one <25% and one >25%). The histochemical aluminium identification disclosed that eight patients of the 70 had aluminium deposits on the the 70 patients, 34 were male, 36 female, and the mean mineralization front (11.4%). All patients but one had age was 48±16 years. All the patients were in dialysis, aluminium deposits on <10% of the bone mineraliz-55 on peritoneal dialysis (PD) and 15 on haemodialysis ation front surface, and all of them had also iron (HD), for a period of 28±22 months before the bone deposits (Figure 2 ). When we compared the presence biopsy was performed. Table 3 depicts the biochemical of iron deposits with the different osteodystrophy data. The mean serum values were: calcium lesions, we found a significantly (P<0.05) greater 8.8±0.9 mg/dl, phosphorus 6.1±1.5 mg/dl, total incidence of this metal (25/31) 
Discussion
Histomorphometric findings
The quantitative histomorphometric results are Our results showed iron deposits on the bone mineralizdepicted in Table 4 and the distribution of the lesions ation front in 61.4% of 70 patients with renal osteodyscan be observed in Figure 1 . The most common lesion trophy. This number is highly significant when was osteitis fibrosa in 31 patients (44.28%); mild compared with the findings from other series osteodystrophy was observed in 20 patients (28.57%); [10, 20, 23, 24] . We reported recently iron deposits at adynamic bone lesion in 15 patients (21.42%); and the mineralization front of the bone biopsies from mixed and osteomalacia were observed in two subjects 10/16 patients that have received kidney transplants respectively (2.28%).
and had remained with normal renal function after a The quantitative percentages of iron and aluminium mean post-graft time of 84 months. Our major question distribution on the bone mineralization front were is the source of the iron. The causes of this issue are particularly noteworthy. As we can see in Table 5 and difficult to explain in our patients. According to the Figure 2 , 43 patients had iron deposits on the bone information of the city Health Service Department, mineralization front (61.4%). Among the 31 patients the amounts of iron, aluminium and other trace metals with osteitis fibrosa, 25 had iron deposits (six <25% in the domestic water supply are within an acceptable range. For many decades, Perl's stain has been used patients was normal, and the mechanisms relating The nomenclature is from [21,22] N, number of patients; % area, the percentage of tissue area that is occupied by osteoid (OAr), fibrosis (FbAr) and mineralized bone (MdAr); % surface, the percentage of the peripheral spicule surface occupied by osteoblasts (ObS) and osteoclasts (OcS); MAR, mineral apposition rate, is the average width of mineral deposited in bone-forming sites per day; BFR, bone formation rate, is the amount of mineral deposited in m2 per mm2 of tissue area per day; normal, 10 normal subjects are used as reference from our laboratory. raised doubts about this point of view. They mentioned that the absorption of neither iron nor aluminium is absorption to body iron stores were intact. In the same mediated via transferrin receptors, but seems to be due report, they studied autopsy material from 22 patients to increased paracellular permeability of the intestine who had been on haemodialysis therapy for 0. [5] [6] [7] [8] in uraemic rats. Nevertheless, the results obtained in years before death and each had received~2.6 g of this study showed high iron deposits and low alumiparenteral iron annually; bone marrow iron deposits nium deposits on the mineralization front. were observed in only four patients. Gratwick et al.
The bone iron deposits were observed in the majority [26 ] found iron deposits on the bone mineralization of the different osteodystrophy diseases. Furthermore, front from frequently transfused patients. The same it was observed that the osteitis fibrosa group contains findings were observed by Pierides and Myli [13] in a high incidence of iron deposits when compared with seven patients with osteomalacia that had received the other renal osteodystrophies. The high incidence numerous transfusions. It is noteworthy that the majorof iron on the bone mineralization front of our patients ity of our patients were on dialysis therapy before with renal osteodystrophy encouraged us to investigate erythropoietin was available and they were receiving the causes of this issue. oral iron (200-300 mg/daily) and blood transfusions The histomorphometric spectrum of the different approximately every 3 months. Unfortunately our renal osteodystrophies was similar to the majority of osteodystrophy patients had not had iron kinetic studthe previous recent series ( Figure 1) . Furthermore, ies which would have allowed us to define their body iron status. On the other hand, it is noteworthy that when we compared our data with those reported a 
